Page 15 - KBM_3_2022_WEB

K. W., Miranda, G. A., Zarnegar, B., Perry, A. K., differentiation of recurrent hepatitis C disease from
Nguyen, B. O., Lane, T. F., Taniguchi, T., Miller, J. acute cellular rejection after liver transplantation. Clin.
F., Cheng, G. Type I interferon production enhances Transplant., 2010, 24, 252–258.
susceptibility to Listeria monocytogenes infection. J. 19. Shaker, O., Ahmed, A., Doss, W., Abdel-Hamid, M.
Exp. Med., 2004, 200, 437–445. MxA expression as marker for assessing the therapeutic
4. Jouanguy E, Zhang, S. Y., Chapgier, A., Sancho- response in HCV genotype 4 Egyptian patients. J. Viral
Shimizu, V., Puel, A., Picard, C., Boisson-Dupuis, Hepat., 2010, 17, 794–799.
S,, Abel, L., Casanova, J. L. Human primary 20. Low, H. H., Lowe, J. Dynamin architecture—from
immunodeficiencies of type I interferons. Biochemie, monomer to polymer. Curr. Opin. Struct. Biol. 2010, 20,
2007, 89, 878–883. 791–798.
5. Makela, M. J., Puhakka, T., Ruuskanen, O., 21. Stertz, S., Reichelt, M., Krijnse-Locker, J.,
Leinonen, M., Saikku, P., Kimpimaki, M. Viruses Mackenzie, J., Simpson, J. C., Haller, O., and
and bacteria in the etiology of the common cold. J. Clin. Kochs, G. Interferon-induced, antiviral human MxA
Microbiol., 1998, 36, 539–542. protein localizes to a distinct subcompartment of the
6. Libertínová, J., Kumstýřová, T., Meluzínová, E., smooth endoplasmic reticulum. J. Interferon Cytokine
Havrdová, E., Horáková, D., Kovářová, I., Hynčicová, Res., 2006, 26, 650–660.
E., Lišková, P., Houžvičková, E., Maťoška, V., Zajac, 22. Miller, S., Krijnse-Locker, J. Modification of
M., Tomek, A., Bojar, M., Marusič, P. mRNA MxA intracellular membrane structures for virus replication.
jako marker biologické účinnosti léčby interferonem-β u Nat. Rev. Microbiol. 2008, 6, 363–374.
pacientů s RS v ČR. Cesk. Slov. Neurol. N., 2009, 72, 23. Accola, M. A., Huang, B., Masri, A. A., McNiven, M.
547–551. A. The antiviral dynamin family member, MxA, tubulates
7. Sadler, A. J., Williams, B. R. Interferon-inducible lipids and localizes to the smooth endoplasmic reticulum.
antiviral effectors. Nat Rev Immunol., 2008, 8, 559–568. J. Biol. Chem., 2002, 277, 21829–21835.
8. Petersen, M. B., Slaugenhaupt, S. A., Lewis, J. 24. Gao S, von der Malsburg, A., Paeschke, S., Behlke,
G., Warren, A. C., Chakravarti, A., Antonarakis, J., Haller, O., Kochs, G., Daumke, O. Structural basis
S. E. A genetic linkage map of 27 markers on human of oligomerisation in the stalk region of dynamin-like
chromosome 21. Genomics, 1991, 9, 407–419. MxA. Nature, 2010, 465, 502– 506.
9. Haller, O., Kochs, G. Human MxA protein: an interferon- 25. Kochs, G., Haller, O. Interferon-induced human
induced dynamin like GTPase with broad antiviral aktivity. MxA GTPase blocks nuclear import of Thogoto virus
J. Interferon Cytokine Res., 2011, 31, 79–87. nucleocapsids. Proc. Natl. Acad. Sci. USA., 1999, 96,
10. Arnheiter, H., Haller, O. Antiviral state against influenza 2082–2086.
virus neutralized by microinjection of antibodies to 26. Beard, K., Chan, C., Mills, S., Poole, S., Brendish, N.
interferon-induced Mx proteins. EMBO J., 1988, 7, J., Clark, T. W. Evaluation of the Febridx Host Response
1315–1320. Point-of-Care Test to Differentiate Viral From Bacterial
11. Mibayashi, M., Nakad, K., Nagata, K. Promoted cell Aetiology in Adults Hospitalized with Acute Respiratory
death of cells expressing human MxA by influenza virus Illness During Influenza Season. Open Forum Infect. Dis.,
infection. Microbiol. Immunol., 2002, 46, 29–36. 2019, 6, S300–S301.
12. Mushinski, J. F., Nguyen, P., Stevens, L. M., 27. Clark, T. W., Brendish, N. J., Poole, S., Naidu, V. V.,
Khanna, C., Lee, S., Chung, E. J., Lee, M. J., Kim, Y. Mansbridge, C., Norton, N., Wheeler, H., Presland,
S., Linehan, W. M., Horisberger, M. A., Trepel, J. B. L., Ewings, S. Diagnostic accuracy of the FebriDx host
Inhibition of tumor cell motility by the interferon-inducible response point-of-care test in patients hospitalised with
GTPase MxA. J. Biol. Chem., 2009, 284, 15206–15214. suspected COVID-19. J. Infect., 2020, 81, 607–613.
13. Tazi-Ahnini, R., di Giovine, F. S., McDonagh, A. J. 28. World Health Organization. (2015). Global action
G., Messenger, A. G., Amadou, C., Cox, A., Duff, plan on antimicrobial resistance. World Health
G. W., Cork, M. J. Structure and polymorphism of Organization. https://apps.who.int/iris/handle/10665
the human gene for the interferon-induced p78 protein /193736
(MX1): evidence of association with alopecia areata in 29. Cals, J. W., Hopstaken, R. M., Butler, C. C., Hood, K.,
the Down syndrome region. Hum. Genet., 2000, 106, Severens, J. L., Dinant, G. J. Improving management
639–645. of patients with acute cough by C-reactive protein point
14. Aebi, M., Fäh, J., Hurt, N., Samuel, C. E., Thomis, of care testing and communication training (IMPAC3T):
D., Bazzigher, L., Pavlovic, J., Haller, O., Staeheli, study protocol of a cluster randomised controlled trial.
P. CDNA structures and regulation of two interferon- BMC Fam. Pract., 2007, 8, 15.
induced human Mx proteins. Mol. Cell. Biol., 1989, 9, 30. Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper,
5062–5072. R. J., Hickner, J. M., Hoffman, J. R., Sande, M. A.
15. Haller, O., Frese, M., Rost, D., Nuttall, P. A., Kochs, Principles of appropriate antibiotic use for treatment of
G. Tick-borne thogoto virus infection in mice is inhibited nonspecific upper respiratory tract infections in adults:
by the orthomyxovirus resistance gene product Mx1. J. background, specific aims, and methods. Ann. Emerg.
Virol., 1995, 69, 2596–2601. Med., 2001, 37, 690–697.
16. Andersson, I., Bladh, L., Mousavi-Jazi, M., 31. Nakabayashi, M., Adachi, Y., Itazawa, T., Okabe, Y.,
Magnusson, K. E., Lundkvist, A., Haller, O., & Kanegane, H., Kawamura, M. MxA-based recognition
Mirazimi, A. Human MxA protein inhibits the replication of viral illness in febrile children by a whole blood assay.
of Crimean-Congo hemorrhagic fever virus. J. Pediatr. Res., 2006, 60, 770–774.
Virol., 2004, 78, 4323–4329. 32. Itazawa, T., Adachi, Y., Nakabayashi, M., Fuchizawa,
17. Gordien, E., Rosmorduc, O., Peltekian, C., Garreau, T., Murakami, G., Miyawaki, T. Theophylline
F., Bréchot, C., Kremsdorf, D. Inhibition of hepatitis B metabolism in acute asthma with MxA-indicated viral
virus replication by the interferon-inducible MxA protein. infection. Pediatr. Int., 2006, 48, 54–57.
J. Virol., 2001, 75, 2684–2691. 33. Ronni, T., Melen, K., Malygin, A., Julkunen, I. Control
18. MacQuillan, G. C., de Boer, W. B., Allan, J. E., of IFN inducible MxA gene expression in human cells. J.
Platten, M. A., Reed, W. D., Jeffrey, G. P. 2010. Immunol., 1993, 150, 1715–26.
Hepatocellular MxA protein expression supports the 34. Huang, N., Morlock, L., Lee, C. H., Chen, L. S.,

Klinická biochemie a metabolismus 3/2022 77